Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Free Cash Flow (2024 - 2026)

Updated

Translational Development Acquisition (TDACU) recorded Free Cash Flow of -$338,753 in Q2 2026, compared with -$171,345 a year earlier.

Analysis

Translational Development Acquisition (TDACU) Free Cash Flow (2024 - 2026) Analysis & Trends

On a TTM basis, Translational Development Acquisition's Free Cash Flow came in at -$849,378 as of Jun 30, 2026; for FY2025, it was -$608,387.

  • Across earlier years, Free Cash Flow came in at -$851,446 in FY2024 and -$204.00 in FY2023.
  • The Q2 2026 figure is the lowest quarterly Free Cash Flow since Q4 2024.
  • Per Business Quant, the preceding three quarters came in at -$305,157 (Q1 2026), -$117,363 (Q4 2025) and -$88,105 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -338,753.00
Mar 31, 2026 -305,157.00
Dec 31, 2025 -117,363.00
Sep 30, 2025 -88,105.00
Jun 30, 2025 -171,345.00
Mar 31, 2025 -231,574.00
Dec 31, 2024 -810,963.00
API Access

Translational Development Acquisition Free Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=free-cash-flow&ticker=TDACU&period=max&api_key=YOUR_API_KEY